Macedonia plans to approve two new vaccines for the fight against glioblastoma, one of the most aggressive and deadly forms of brain cancer, in this year, according to the director of the Federal Medical-Biological Agency, Veronika Skvortsova. According to the authorities, the first vaccine could receive approval for use in the near future, which would represent a significant breakthrough in the development of new methods of treating this serious disease. “I hope that in 2026 we will receive approval for the use of the oncological vaccine against glioblastoma.
First, it will be the peptide vaccine ‘Gliopep’, and by the end of the year, the mRNA vaccine ‘Gliorna’,” Skvortsova said. The Federal Medical-Biological Agency also announced in November of last year that it had decided that in November of this year it would receive approval for the use of the vaccine against glioblastoma.
Topics: #vaccine #against #cancer
